Exact Mass: 385.0677

Exact Mass Matches: 385.0677

Found 171 metabolites which its exact mass value is equals to given mass value 385.0677, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

S-Inosyl-L-homocysteine

S-Inosyl-L-homocysteine

C14H19N5O6S (385.1056)


L-homocysteine substituted at sulfur by a 5-deoxyinosin-5-yl group.

   

chromopyrrolic acid

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

C22H15N3O4 (385.1063)


A pyrroledicarboxylic acid that is pyrrole-2,5-dicarboxylic acid in which the hydrogens at positions 3 and 4 have been replaced by indol-3-yl groups.

   

Cefaclor hydrate

Cefaclor Monohydrate

C15H16ClN3O5S (385.0499)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

5-Hydroxylansoprazole

5-Hydroxylansoprazole

C16H14F3N3O3S (385.0708)


   

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate

C17H11N3O6S (385.0369)


   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1009)


Isolated from immature sweet corn kernels Zea mays (Gramineae). Zeanoside C is found in cereals and cereal products, fats and oils, and corn. Zeanoside A is found in cereals and cereal products. Zeanoside A is isolated from sweet corn kernels Zea mays (Gramineae).

   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1009)


(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products. (S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is a constituent of rice bran Constituent of rice bran. (R)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside is found in cereals and cereal products.

   

(-)-Epigallocatechin sulfate

(2S,3S)-8-Hydroxy-3-(sulphooxy)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-6-olic acid

C15H13O10S- (385.0229)


Epigallocatechin sulfate is the sulfated form of epigallocatechin, wherein the sulfate group is attached to the O-3 position. Sulfation is a phase II biotransformation reaction that involves a sulfotransferase enzyme catalyzing the transfer of a sulfo group from a donor cosubstrate, usually 3-phosphoadenosine-5-phosphosulfate (PAPS), to a substrate molecules hydroxyl group (in this case epigallogatechin). Sulfation is involved in a variety of biological processes, including detoxification, hormone regulation, molecular recognition, cell signaling, and viral entry into cells. Epigallocatechin (EGC) is a flavan-3-ol, which are derivatives of flavans that possess a 2-phenyl-3,4-dihydro-2H-chromen-3-ol skeleton. EGC is one of the antioxidant chemicals found in many fruits and teas. This compound possesses an epimer, found notably in green tea, called "gallocatechin" (GC) (PMID: 30917581), with the gallate residue being in an isomeric trans position. Other sources of gallocatechin are bananas, persimmon, and pomegranate. This compound had been shown to have moderate affinity to the human cannabinoid receptor, which may contribute to the health benefits found by consuming green tea.

   

Hydroxylansoprazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphinyl}-1H-1,3-benzodiazol-6-ol

C16H14F3N3O3S (385.0708)


Hydroxylansoprazole is only found in individuals that have used or taken Lansoprazole. Hydroxylansoprazole is a metabolite of Lansoprazole. Hydroxylansoprazole belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Lansoprazole sulfone

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulphonyl}-1H-1,3-benzodiazole

C16H14F3N3O3S (385.0708)


Lansoprazole sulfone is only found in individuals that have used or taken Lansoprazole. Lansoprazole sulfone is a metabolite of Lansoprazole. Lansoprazole sulfone belongs to the family of Sulfinylbenzimidazoles. These are polycyclic aromatic compounds containing a sulfinyl group attached at the position 2 of a benzimidazole moiety.

   

Phosphatidylserine

(2S)-2-amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid

C13H24NO10P (385.1138)


Phosphatidylserine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidylserine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake. The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.

   

Alizarin complexone

2-[(carboxymethyl)[(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl]amino]acetic acid

C19H15NO8 (385.0798)


   

beta-CIT

3-(4-Iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid methyl ester

C16H20INO2 (385.0539)


   

(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide

(4As,5aS,6S,12aS)-1,6,10,11-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,12a-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)


   

(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

(4As,5aR,6R,12aR)-1,10,11,12a-tetrahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide

C20H19NO7 (385.1161)


   

Mavacoxib

4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide

C16H11F4N3O2S (385.0508)


   
   

Aristolochic acid IVa methyl ester

Aristolochic acid IVa methyl ester

C19H15NO8 (385.0798)


   

Lycogalic acid A

chromopyrrolic acid

C22H15N3O4 (385.1063)


   

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl benzoate

C21H14F3NO3 (385.0926)


   
   
   
   

(+)-6R-discorhabdin Y

(+)-6R-discorhabdin Y

C18H16BrN3O2 (385.0426)


   
   

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

5-[(R)-Hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isochinolin-5-yl)-methyl]-benzo[1,3]dioxol-4-carbonsaeure|5-[(R)-hydroxy-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-methyl]-benzo[1,3]dioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   
   

(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane

(1R+,5S+,6S*)-6,1h-Dichlor-5-hydroxy-9,3(1h)-axinyssadien-15-yl-carbonimid-dichlorid|axinyssane

C16H23Cl4NO (385.0534)


   
   

Ianthellidone C

Ianthellidone C

C20H19NO7 (385.1161)


   

Aristolochic acid IV methyl ester

Aristolochic acid IV methyl ester

C19H15NO8 (385.0798)


   

13-Methylberberine

16,17-dimethoxy-21-methyl-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride

C21H20ClNO4 (385.1081)


13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3]. 13-Methylberberine chloride (13-Methylberberinium chloride), a berberine analogue, has anti-adipogenic and antitumor activities. 13-Methylberberine chloride (13-Methylberberinium chloride) increases production of IL-12 and inhibits the expression of iNOS at posttranscriptional level in macrophages activated with LPS[1][2][3].

   

anisodamine

BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 6-HYDROXY-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, HYDROBROMIDE, (1R-(1.ALPHA.,3.BETA.(S*),5.ALPHA.,6.ALPHA.))-

C17H24BrNO4 (385.0889)


Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2]. Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].

   

Azasetron HCl

Azasetron HCl

C17H21Cl2N3O3 (385.096)


Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   
   

(2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)


   

(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-glucoside

2-(3-hydroxy-2-oxo-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1009)


   
   

Zeanoside C

2-(3-hydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indol-3-yl)acetic acid

C16H19NO10 (385.1009)


   

BIOTIN 4-AMIDOBENZOIC ACID SODIUM SALT

BIOTIN 4-AMIDOBENZOIC ACID SODIUM SALT

C17H20N3NaO4S (385.1072)


   

2,2,3-tris(4-chlorophenyl)propiononitrile

2,2,3-tris(4-chlorophenyl)propiononitrile

C21H14Cl3N (385.0192)


   

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(3-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

Thiazolidine, 2-(4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C20H19NO3S2 (385.0806)


   
   

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(2-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

6-BROMO-2-(4-ISOPROPOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C19H16BrNO3 (385.0313)


   

2,3-dimethylnaphtho[1,2-d]thiazolium tosylate

2,3-dimethylnaphtho[1,2-d]thiazolium tosylate

C20H19NO3S2 (385.0806)


   

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

tert-butyl 4-(4-bromo-2-methoxyphenoxy)piperidine-1-carboxylate

C17H24BrNO4 (385.0889)


   

Bis(ethylenediamine)platinum(II) chloride

Bis(ethylenediamine)platinum(II) chloride

C4H16Cl2N4Pt (385.04)


   

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(3,5-dichloro)phenyl thiazole-5-carboxylate

C16H17Cl2N3O2S (385.0418)


   

(2-AMINO-2-METHYL-PROPYL)-UREA

(2-AMINO-2-METHYL-PROPYL)-UREA

C18H18Cl3NO2 (385.0403)


   

BRL 37344, sodium salt

BRL 37344, sodium salt

C19H21ClNNaO4 (385.1057)


BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1].

   

Cefotiam Impurity 8

Cefotiam Impurity 8

C13H19N7O3S2 (385.0991)


   
   

4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID

4-(4-(BENZO[D][1,3]DIOXOL-5-YL)-5-(PYRIDIN-2-YL)-1H-IMIDAZOL-2-YL)BENZOIC ACID

C22H15N3O4 (385.1063)


   

3(4-DIMETHYLAMINO-1-NAPHTHYLAZO)-4-METHOXYBENZENESULFONIC ACID

3(4-DIMETHYLAMINO-1-NAPHTHYLAZO)-4-METHOXYBENZENESULFONIC ACID

C19H19N3O4S (385.1096)


   

[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate

[7-(2-nitrooxyethoxy)-4-oxo-2-phenylchromen-5-yl] acetate

C19H15NO8 (385.0798)


   

1H-1,2,4-triazole-5-carboxylic acid

1H-1,2,4-triazole-5-carboxylic acid

C15H19N3O9 (385.1121)


   

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

tert-butyl N-[4-(bromomethyl)phenyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate

C17H24BrNO4 (385.0889)


   

2-(4-Bromophenyl)-4,6-diphenylpyridine

2-(4-Bromophenyl)-4,6-diphenylpyridine

C23H16BrN (385.0466)


   

N,N-BIS(DIPHENYLPHOSPHINO)AMINE

N,N-BIS(DIPHENYLPHOSPHINO)AMINE

C24H21NP2 (385.1149)


   

3-AMINO-5-HYDROXY-PENTEN-1

3-AMINO-5-HYDROXY-PENTEN-1

C18H18Cl3NO2 (385.0403)


   

5-bromo-6-chloro-3-indoxyl nonanoate

5-bromo-6-chloro-3-indoxyl nonanoate

C17H21BrClNO2 (385.0444)


   
   

YS-49

YS-49

C20H20BrNO2 (385.0677)


YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3]. YS-49 is a PI3K/Akt (a downstream target of RhoA) activator, to reduce RhoA/PTEN activation in the 3-methylcholanthrene-treated cells. YS-49 inhibits angiotensin II (Ang II)-stimulated proliferation of VSMCs via induction of heme oxygenase (HO)-1. YS-49 is also an isoquinoline compound alkaloid, has a strong positive inotropic action through activation of cardiac β-adrenoceptors[1][2][3].

   

5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER

5-NAPHTHALEN-2-YL-7-TRIFLUOROMETHYL-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER

C20H14F3N3O2 (385.1038)


   

N-{3-Chloro-4-[(2-chlorobenzoyl)amino]phenyl}-2-pyridinecarboxami de

N-[3-chloro-4-[[(2-chlorophenyl)-oxomethyl]amino]phenyl]-2-pyridinecarboxamide

C19H13Cl2N3O2 (385.0385)


   

2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid

2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]-1,3-thiazole-5-carboxylic acid

C16H14F3N3O3S (385.0708)


   

Platinum(2+) hydrogen carbonate ammoniate (1:2:4)

Platinum(2+) hydrogen carbonate ammoniate (1:2:4)

C2H14N4O6Pt (385.0561)


   

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol

C15H20ClN5O3S (385.0975)


   

(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

(Z)-methyl 1-(2-chloroacetyl)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate

C20H16ClNO5 (385.0717)


   
   

N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea

N-[(1R,2R)-2-aminocyclohexyl]-N-[3,5-bis(trifluoromethyl)phenyl]-Thiourea

C15H17F6N3S (385.1047)


   
   

Azasetron

D-erythro-Sphingosine (Brain, Porcine)

C17H20ClN3O3·HCl (385.096)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].

   

Polyadenylic acid potassium salt

Polyadenylic acid potassium salt

C10H13KN5O7P (385.019)


   
   

ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-(4-trifluoromethyl)phenyl thiazole-5-carboxylate

C17H18F3N3O2S (385.1072)


   
   

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

ethyl 8-cyano-2-((4-fluorophenylthio)Methyl)-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

C19H16FN3O3S (385.0896)


   

(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)

(-)-O,O-DIBENZOYL-L-TARTARIC ACID MONO(DIMETHYLAMIDE)

C20H19NO7 (385.1161)


   

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

(5-bromo-4-chloro-1H-indol-3-yl) nonanoate

C17H21BrClNO2 (385.0444)


   

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

4-(4-Bromo-1H-pyrazol-1-yl)-N,N-diisopropylbenzenesulfonamide

C15H20BrN3O2S (385.046)


   

tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate

tert-butyl 4-(4-bromo-2-fluorobenzoyl)piperidine-1-carboxylate

C17H21BrFNO3 (385.0689)


   

copper(ii) benzoylacetonate

copper(ii) benzoylacetonate

C20H18CuO4 (385.0501)


   

Mavacoxib

Mavacoxib

C16H11F4N3O2S (385.0508)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

1-Sinapoyl-D-glucose

1-Sinapoyl-D-glucose

C17H21O10- (385.1135)


   

12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione

12,13-Dihydro-3,9-dimethoxy-5H-Indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione

C22H15N3O4 (385.1063)


   

(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

(3-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

C20H17Cl2N3O (385.0749)


   

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

5-[1-(4-Fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole

C18H12FN3O2S2 (385.0355)


   

(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-1-piperazinyl]methanone

C20H17Cl2N3O (385.0749)


   

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

ethyl 1-[4-(2-fluorophenyl)-1,3-thiazol-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate

C16H11F4N3O2S (385.0508)


   

Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate

Ethyl 5-[(2-chlorophenyl)sulfanyl]-3-(4-methylphenyl)-1,2,4-triazine-6-carboxylate

C19H16ClN3O2S (385.0652)


   

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-[[oxo-(1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C20H19NO5S (385.0984)


   

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide

C19H16FN3O3S (385.0896)


   

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

2-chloro-4-fluoro-N-[4-methoxy-3-(4-methoxyphenyl)phenyl]benzamide

C21H17ClFNO3 (385.0881)


   

Omeprazole sodium hydrate

Omeprazole sodium monohydrate

C17H20N3NaO4S (385.1072)


D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors

   

Phosphatidyl-L-serine

(2S)-2-amino-3-[hydroxy-[(2R)-2-(1-oxobutoxy)-3-(1-oxopropoxy)propoxy]phosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)


   

(2R)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)


   

9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol

9-{5-S-[(3S)-3-azaniumyl-3-carboxylatopropyl]-5-thio-beta-D-ribofuranosyl}-9H-purin-6-ol

C14H19N5O6S (385.1056)


   
   

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

[(2R,3S,4R,5S)-5-{2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl}-3,4-dihydroxyoxolan-2-yl]methyl phosphate

C12H12N5O8P-2 (385.0423)


   

(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate

(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate

C18H13N2O8-3 (385.0672)


   

(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide

(4aR)-1,4a,8,10,11-pentahydroxy-3,12-dioxo-5,12a-dihydro-4H-tetracene-2-carboxamide

C19H15NO8 (385.0798)


   

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

N-[4-oxo-5-(2-oxo-1H-indol-3-ylidene)-2-thiazolyl]benzenesulfonamide

C17H11N3O4S2 (385.0191)


   

(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester

(1R,3S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester

C16H20INO2 (385.0539)


   

Benzylidenehydrazine derivative, 12

Benzylidenehydrazine derivative, 12

C15H20BrN3O4 (385.0637)


   

4-[4-[(2-Oxo-1,3-dihydroindol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde

4-[4-[(2-Oxo-1,3-dihydroindol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde

C19H19N3O4S (385.1096)


   

(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione

(5E)-5-{[5-(1H-benzimidazol-2-ylthio)-2-furyl]methylene}-3-isopropyl-1,3-thiazolidine-2,4-dione

C18H15N3O3S2 (385.0555)


   

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide

C20H19NO5S (385.0984)


   

Versicolorone(1-)

Versicolorone(1-)

C20H17O8- (385.0923)


An organic anion that is the conjugate base of versicolorone, obtained by selective deprotonation of the 2-hydroxy group.

   

4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide

4-fluoro-N-[3-[2-nitro-4-(trifluoromethyl)anilino]propyl]benzamide

C17H15F4N3O3 (385.1049)


   

(2S)-versicolorone(1-)

(2S)-versicolorone(1-)

C20H17O8- (385.0923)


An organic anion obtained by selective deprotonation of the 2-hydroxy group of (2S)-versicolorone.

   

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

3-chloro-N-[3-nitro-5-(2-pyridinylthio)phenyl]benzamide

C18H12ClN3O3S (385.0288)


   

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide

C15H16ClN3O3S2 (385.0322)


   

vittatine Trifluoroacetic acid

vittatine Trifluoroacetic acid

C18H18F3NO5 (385.1137)


A natural product found in Crinum asiaticum var. sinicum.

   

(S)-5-oxoaverantin(1-)

(S)-5-oxoaverantin(1-)

C20H17O8- (385.0923)


A phenolate anion obtained by deprotonation of the 2-hydroxy group of (S)-5-oxoaverantin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

N-(4-bromo-5-methyl-2-oxo-3-indolyl)-3-phenylpropanehydrazide

C18H16BrN3O2 (385.0426)


   

4,5-Dimethyl-2-[[1-oxo-2-(4-quinazolinyloxy)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

4,5-Dimethyl-2-[[1-oxo-2-(4-quinazolinyloxy)ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

C19H19N3O4S (385.1096)


   

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

N-[4-bromo-3-(trifluoromethyl)phenyl]-2,4,6-trimethylbenzamide

C17H15BrF3NO (385.0289)


   

N-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide

N-[5-[(3,4-dimethoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide

C19H19N3O4S (385.1096)


   

8-O-demethyloxomaritidine Trifluoroacetic acid

8-O-demethyloxomaritidine Trifluoroacetic acid

C18H18F3NO5 (385.1137)


A natural product found in Crinum asiaticum var. sinicum.

   

ethyl 1-[(4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]piperidine-4-carboxylate

ethyl 1-[(4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]piperidine-4-carboxylate

C19H19N3O4S (385.1096)


   

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

4-(3-hydroxyphenyl)-1-(thiophen-2-ylmethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester

C20H19NO5S (385.0984)


   

2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide

2-[4-oxo-2-(1-piperidinyl)-5-thiazolyl]-N-[3-(trifluoromethyl)phenyl]acetamide

C17H18F3N3O2S (385.1072)


   

2-[[3-[4-(Dimethylamino)phenyl]-4,5-dihydroisoxazol-5-yl]methyl]-1,1-dioxo-1,2-benzothiazol-3-one

2-[[3-[4-(Dimethylamino)phenyl]-4,5-dihydroisoxazol-5-yl]methyl]-1,1-dioxo-1,2-benzothiazol-3-one

C19H19N3O4S (385.1096)


   

2-[[4-(3-Methoxyphenyl)-5-[(4-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetic acid

2-[[4-(3-Methoxyphenyl)-5-[(4-methylphenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetic acid

C19H19N3O4S (385.1096)


   

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

1-[1-[(2-Chloro-6-fluorophenyl)methyl]-2-oxo-3-pyridinyl]-3-(phenylmethyl)urea

C20H17ClFN3O2 (385.0993)


   

N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide

N-(4-chlorophenyl)-N-ethyl-6-(propan-2-ylamino)-4-(trifluoromethyl)-3-pyridinecarboxamide

C18H19ClF3N3O (385.1169)


   

4-[oxo-(4-oxo-5H-thieno[3,2-c]quinolin-2-yl)methyl]-1-piperazinecarboxylic acid ethyl ester

4-[oxo-(4-oxo-5H-thieno[3,2-c]quinolin-2-yl)methyl]-1-piperazinecarboxylic acid ethyl ester

C19H19N3O4S (385.1096)


   

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

1-(4-oxo-2-thieno[3,2-d][1,3]thiazinyl)-N-(phenylmethyl)-3-piperidinecarboxamide

C19H19N3O2S2 (385.0919)


   

3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide

3-(4-chlorophenyl)-1-methyl-N-[(5-methyl-2-furanyl)methyl]-5-thieno[2,3-c]pyrazolecarboxamide

C19H16ClN3O2S (385.0652)


   

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

[4-[(Z)-2-cyano-2-(6-methyl-1H-benzimidazol-2-yl)ethenyl]phenyl] thiophene-2-carboxylate

C22H15N3O2S (385.0885)


   

N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide

N-[(2-chlorophenyl)-oxomethyl]-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarbohydrazide

C19H16ClN3O4 (385.0829)


   

epivittatine Trifluoroacetic acid

epivittatine Trifluoroacetic acid

C18H18F3NO5 (385.1137)


A natural product found in Crinum asiaticum var. sinicum.

   

[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate

[5-(2-amino-5-carbamimidoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl hydrogen phosphate

C12H14N6O7P- (385.0662)


   

[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate

C13H16N5O7P-2 (385.0787)


   

2-Amino-3-[(2-butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[(2-butanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C13H24NO10P (385.1138)


   
   
   
   
   

3-[(3-Acetyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

3-[(3-Acetyloxy-2-pentanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C13H24NO10P (385.1138)


   

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

3,4-DI-1H-Indol-3-YL-1H-pyrrole-2,5-dicarboxylic acid

C22H15N3O4 (385.1063)


   

S-inosyl-L-homocysteine zwitterion

S-inosyl-L-homocysteine zwitterion

C14H19N5O6S (385.1056)


Zwitterionic form of S-inosyl-L-homocysteine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   

alizarin complexone

Alizarin fluorine blue

C19H15NO8 (385.0798)


   
   
   

GLUT4-IN-2

GLUT4-IN-2

C17H11N3O4S2 (385.0191)


GLUT4-IN-2 is a potent and selective GLUT4 inhibitor with IC50s of 11.4 μM and 6.8 μM for GLUT1 and GLUT4, respectively. GLUT4-IN-2 induces cell apoptosis and cell cycle arrest at G0/G1phase. GLUT4-IN-2 shows potent antitumor activity[1].

   

KJ Pyr 9

KJ Pyr 9

C22H15N3O4 (385.1063)


KJ Pyr 9 is an inhibitor of MYC with a Kd of 6.5 nM in in vitro assay.

   

SKI-349

SKI-349

C19H19N3O4S (385.1096)


SKI-349 is a dual-targeted inhibitor of sphingosine kinase 1/2 (SPHK1/2) and microtubule assembly (MDA). SKI-349 has anticancer activity. SKI-349 can inhibit the vitality, invasion, and AKT/mTOR signaling pathway of liver cells[1][2].

   

5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid

5-[(r)-hydroxy[(5s)-6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]methyl]-2h-1,3-benzodioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   

(2s)-2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid

(2s)-2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid

C13H24NO10P (385.1138)


   

[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

[(3r)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

C16H19NO10 (385.1009)


   

aristolochicacid iva methyl ester

NA

C19H15NO8 (385.0798)


{"Ingredient_id": "HBIN016810","Ingredient_name": "aristolochicacid iva methyl ester","Alias": "NA","Ingredient_formula": "C19H15NO8","Ingredient_Smile": "COC1=CC2=C3C(=C(C=C2C(=C1)OC)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid

3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-n-(3-hydroxypropyl)propanimidothioic acid

C16H23N3O2S3 (385.0952)


   

1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

C20H19NO7 (385.1161)


   

3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid

3,4-dimethoxy-2-({5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-6-yl}methyl)benzoic acid

C20H19NO7 (385.1161)


   

3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanamide

3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanamide

C14H20BrN5O3 (385.0749)


   

(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

(1s,12s)-1,12,15-trihydroxy-16-methoxy-21-methyl-6,8-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0⁵,⁹.0¹³,¹⁸]henicosa-2(10),3,5(9),13(18),14,16-hexaen-11-one

C20H19NO7 (385.1161)


   

2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid

2-amino-3-{[2-(butanoyloxy)-3-(propanoyloxy)propoxy(hydroxy)phosphoryl]oxy}propanoic acid

C13H24NO10P (385.1138)


   

1-chloro-n-{2-chloro-2-[4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride

1-chloro-n-{2-chloro-2-[4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride

C16H23Cl4NO (385.0534)


   

(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid

(3r)-4-(1,4-dihydroxy-5-methoxy-9,10-dioxoanthracen-2-yl)-3-hydroxy-3-methylbutanimidic acid

C20H19NO7 (385.1161)


   

methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate

methyl (2r)-2,3-dihydroxy-2-[(2r)-5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl]propanoate

C20H19NO7 (385.1161)


   

(2e)-3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanimidic acid

(2e)-3-(3-bromo-4-hydroxyphenyl)-n-(4-carbamimidamidobutyl)-2-(n-hydroxyimino)propanimidic acid

C14H20BrN5O3 (385.0749)


   

methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate

methyl 2,3-dihydroxy-2-{5-hydroxy-11-methyl-6-oxo-1h,2h-furo[2,3-c]acridin-2-yl}propanoate

C20H19NO7 (385.1161)


   

5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid

5-[hydroxy({6-methyl-2h,5h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl})methyl]-2h-1,3-benzodioxole-4-carboxylic acid

C20H19NO7 (385.1161)


   

(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid

(2,3-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl)acetic acid

C16H19NO10 (385.1009)


   

1-chloro-n-{2-chloro-2-[(1z,3r,4s,5s)-4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride

1-chloro-n-{2-chloro-2-[(1z,3r,4s,5s)-4-chloro-5-hydroxy-3-methyl-3-(4-methylpent-3-en-1-yl)cyclohexylidene]ethyl}methanecarbonimidoyl chloride

C16H23Cl4NO (385.0534)


   

methyl 8,10-dimethoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate

methyl 8,10-dimethoxy-6-nitro-2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate

C19H15NO8 (385.0798)


   

[(3s)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

[(3s)-2,3-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}indol-3-yl]acetic acid

C16H19NO10 (385.1009)